p.lindqvist
TL2 · Beirut
Contributes reviews on supplier material. Based in Beirut.
Joined 22 January 2025 · last posted 9d
69 posts, newest first. Showing up to 150.
-
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #7 · Compounds › Retatrutide · 18 Jul 2026 · 5 likes Discontinuation for adverse effects in phase 2 was not negligible at the higher doses. That figure belongs next to the efficacy figure whenever the efficacy figure is…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #52 · Clinical › Prescriber conversations · 18 Jul 2026 · 15 likes Where I part company with post #51, and it is a narrow parting. The most useful thing anyone has posted about prescriber in this category was a table of what had been…
-
How much context is too much context in a first post? Replied, post #55 · Start Here › How to Ask · 9 Jul 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
-
What TRIUMPH is designed to answer, and why we should not pre-empt it Replied, post #6 · Compounds › Retatrutide · 8 Jul 2026 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #16 · Analytics › HPLC & UHPLC · 6 Jul 2026 · 0 likes The arithmetic on Detection wavelength is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #34 · Evidence › Trials · 3 Jul 2026 · 19 likes Registration before enrolment, with the primary endpoint declared, is what makes outcome switching detectable. Checking the registry against the paper takes five…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #39 · Compounds › Retatrutide · 2 Jul 2026 · 0 likes I have been on both sides of the TRIUMPH argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #88 · Compounds › Semaglutide · 28 Jun 2026 · 23 likes This follows post #85 rather than contradicting it. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters.…
-
Follow-up: Signs of dehydration worth acting on Replied, post #7 · Safety › Adverse events · 27 Jun 2026 · 3 likes That is clearer than the version I had in my head. Thank you.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #103 · Outcomes › Body composition · 27 Jun 2026 · 28 likes Source for the Lean mass preservation figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…
-
Aggregate verification data across the directory, with caveats Replied, post #14 · Sourcing › Independent verification · 26 Jun 2026 · 3 likes Understood, and I withdraw the assumption I opened with.
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #22 · Sourcing › Independent verification · 16 Jun 2026 · 28 likes Coming back to post #18, because the follow-up matters more than the original answer. Speaking only to Interpreting a result as I have actually seen it, rather than as…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #45 · Analytics › Impurities & related substances · 13 Jun 2026 · 30 likes Endotoxin is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes before…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #34 · Analytics › Method validation · 27 May 2026 · 32 likes I would keep Specificity and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #66 · Clinical › Bloodwork · 13 May 2026 · 2 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #41 · Analytics › HPLC & UHPLC · 9 May 2026 · 29 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #19 · Pharmacology › Formulation chemistry · 30 Apr 2026 · 1 like Taking Solubility limits seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #98 · Practice › Dosing & titration · 25 Apr 2026 · 1 like I read post #94 twice before replying, because I had assumed the opposite. Concentration and dose get conflated constantly in this subcategory. Changing how much…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #72 · Practice › Side effects · 24 Apr 2026 · 24 likes Post #68 describes the usual case. This is about the unusual one. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not…
-
Fasting versus non-fasting and which tests care Replied, post #16 · Clinical › Bloodwork · 22 Apr 2026 · 10 likes Fasting versus non-fasting was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Transporting a vial for a weekend away — a second dataset Replied, post #30 · Practice › Storage & stability · 17 Apr 2026 · 31 likes Agreed on all of that, and I have nothing to add to it.
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #13 · Research Methods › Statistics · 6 Apr 2026 · 0 likes The version of Sample size intuition that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
Second pass at: Identical chromatograms across two different lots Replied, post #83 · Sourcing › Red flags · 21 Mar 2026 · 0 likes Before the thread moves on from Identical chromatograms — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an…
-
Second pass at: Identical chromatograms across two different lots Replied, post #68 · Sourcing › Red flags · 15 Mar 2026 · 7 likes Reporting something here requires the batch, the date, the method and the document, which is exactly what makes the reports worth reading two years later.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #28 · Practice › Administration · 4 Mar 2026 · 31 likes Letting a refrigerated preparation come to room temperature before injecting reduces the sting for most people. It is not a stability requirement, it is a comfort one,…
-
Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit? Replied, post #4 · Compounds › Semaglutide · 24 Feb 2026 · 2 likes The oral formulation is a genuinely different pharmaceutical problem from the injectable and shares only the active molecule. Absorption enhancers, fasting requirements…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #32 · Research Methods › Statistics · 14 Feb 2026 · 0 likes I changed my mind about Measurement error in home scales after someone here asked me for the source and I could not produce one. That is worth saying out loud because…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #9 · Analytics › Mass spectrometry · 11 Feb 2026 · 2 likes Adding what did not work for me on mass error in ppm, since the failures never get written up and they are half the useful information.
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #16 · Evidence › Trials · 21 Jan 2026 · 0 likes Reading a supplementary appendix is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly.…
-
The headache that turns out to be dehydration Replied, post #138 · Nutrition & Training › Hydration & electrolytes · 14 Jan 2026 · 1 like The arithmetic in post #135 is right; the assumption feeding it is the part to check. Headache is a good example of a question where the honest answer is boring and the…
-
Constipation management, with a dietitian's contribution Replied, post #16 · Practice › Side effects · 5 Jan 2026 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #32 · Regional › UK & Ireland · 2 Jan 2026 · 0 likes An update on my earlier Private prescribing post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #50 · Access › Pricing · 31 Dec 2025 · 10 likes Picking up post #48: that is the part I would want checked first. Comparing a licensed product's price to a research-use-only preparation's price is comparing two…
-
A history of disordered eating: proceeding carefully Replied, post #45 · Wellbeing › Mental health · 31 Dec 2025 · 16 likes I read post #43 twice before replying, because I had assumed the opposite. Eating-disorder history is raised here regularly and is the case where guidance most…
-
Specification in the result column: why that is a meaningful error Replied, post #95 · Analytics › COA interpretation · 26 Dec 2025 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #11 · Compounds › Tirzepatide · 11 Dec 2025 · 24 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #49 · Wellbeing › Mental health · 12 Nov 2025 · 3 likes Post #47 describes the usual case. This is about the unusual one. Support and community: some people process weight change through community (online or in-person).…
-
How to ask about something you suspect is a bad idea Replied, post #24 · Start Here › How to Ask · 11 Nov 2025 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
[2026 update] What steady state means for the decision to escalate Replied, post #49 · Practice › Dosing & titration · 10 Nov 2025 · 2 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Angle of injection and whether 90 degrees is always right Replied, post #47 · Practice › Administration · 8 Nov 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Replied, post #8 · Compounds › Tirzepatide · 3 Nov 2025 · 6 likes Helpful, and short, which on this subject is harder than long.
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #7 · marked as the solution · Start Here › Welcome · 29 Oct 2025 · 28 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
EMA product information as a primary source Replied, post #10 · Regional › European Union · 28 Oct 2025 · 1 like Language versions of the product information are all official and occasionally differ in emphasis. Where a detail matters, reading two is not paranoid. Two sources,…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #48 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 31 likes Picking up post #45: that is the part I would want checked first. The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass…
-
Reading a supplier's product description as a marketing document Replied, post #62 · Compounds › Other compounds · 26 Aug 2025 · 26 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Trial registration and comparing the protocol with the paper Replied, post #28 · Evidence › Trials · 9 Aug 2025 · 10 likes The arithmetic in post #27 is right; the assumption feeding it is the part to check. Funding and trial conduct should be stated and are a weak predictor of anything on…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #10 · Practice › Storage & stability · 31 Jul 2025 · 14 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
-
What a documentation review can and cannot tell you Replied, post #47 · Sourcing › Independent verification · 25 Jul 2025 · 0 likes Reading this documentation review thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
When a tidy document is a signal and when it is decoration Replied, post #7 · Analytics › COA interpretation · 23 Jul 2025 · 3 likes The signature block matters more than it appears to. A named individual with a date is a different kind of document from an unsigned one, whatever the numbers say.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #56 · Data & Tools › Calculators · 19 Jul 2025 · 0 likes Post #54 and I disagree about the size of the effect, not about the direction. A tool that refuses to give an answer when the result falls below one graduation is doing…
-
Interpreting a composition change that is within the error bars Replied, post #8 · Outcomes › Body composition · 26 Jun 2025 · 22 likes Post #4 describes the usual case. This is about the unusual one. Summarising the interpreting a composition change thread so far, since it is long and the answer is…
-
Tracking that stops updating and then resumes Replied, post #5 · Sourcing › Logistics · 22 Jun 2025 · 2 likes Adding the measurement that post #2 says would settle it. Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually…
-
A well-designed study with a badly written abstract Replied, post #128 · Evidence › Study critique · 4 Jun 2025 · 0 likes Building on post #127 rather than restating it. Agreed on well-designed study, with one qualification that I think matters. The reasoning holds for the case as…
-
Asking about a compound your prescriber has not heard of Replied, post #53 · Clinical › Prescriber conversations · 31 May 2025 · 4 likes Post #50 is the version of this I will quote in future. One addition. A question phrased as "what would you want to see before considering X" is answerable and is not a…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #91 · Clinical › Comorbidities · 21 May 2025 · 7 likes PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is…
-
Pregnancy as an absolute contraindication Replied, post #4 · Safety › Contraindications · 16 May 2025 · 7 likes Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring for hypoglycemia. The combination is used with…
-
Revisiting: German, French and Dutch differences, compared Replied, post #17 · Regional › European Union · 1 May 2025 · 1 like A definition problem is doing most of the work in this German discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is…
-
Ipamorelin selectivity claims and where they came from Replied, post #29 · Compounds › Secretagogues & GH axis · 16 Apr 2025 · 1 like Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #47 · Practice › Reconstitution · 22 Mar 2025 · 2 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #57 · Pharmacology › Receptor biology · 7 Mar 2025 · 9 likes Coming back to post #54, because the follow-up matters more than the original answer. What I would tell a new member reading about biased agonism for the first time:…
-
When to suspect the method rather than the sample Replied, post #89 · Analytics › Method validation · 28 Feb 2025 · 3 likes Saving this. It is the version I will quote when the question comes round again.
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #15 · Compounds › Secretagogues & GH axis · 3 Jan 2025 · 14 likes On well-designed human trial, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Second pass at: A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #6 · Devices › Pens & autoinjectors · 31 Dec 2024 · 3 likes Post #3 is right about the mechanism and I think understates the practical bit. A pen that has been dropped may not be visibly damaged and may not deliver accurately…
-
Building a sensible monitoring schedule with your prescriber Replied, post #59 · Clinical › Bloodwork · 21 Dec 2024 · 9 likes Building a sensible monitoring schedule was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #61 · Practice › Administration · 28 Sep 2024 · 9 likes On site rotation scheme, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #18 · Nutrition & Training › Protein & intake · 19 Sep 2024 · 22 likes Fibre and fluid tend to fall alongside protein when intake drops, and the constipation reported here follows from that as much as from the mechanism.
-
Chronic kidney disease and the FLOW result Replied, post #38 · Clinical › Comorbidities · 23 Aug 2024 · 0 likes The question underneath chronic kidney disease is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #6 · Sourcing › Red flags · 21 Jul 2024 · 0 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at…
-
Cold packs, phase-change material, and what survives ten days Replied, post #21 · Sourcing › Logistics · 17 Jun 2024 · 0 likes Post #19 describes the usual case. This is about the unusual one. Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before…